“…One possible explanation is the small sample size, where there are only 12 Her2 subtypes. We similarly investigated the top 10 genes out of the 94 genes uniquely selected by pETM from 109 uniquely selected sites and found that 9 genes were reported to be associated with cancers: CLTC (P€ arssinen et al, 2007) and NSD1 (Stephens et al, 2009) were reported to be associated with breast cancer; SLC25A2 (Motamedian et al, 2015) and ESRRA (Micci et al, 2014) were reported to be associated with ovarian cancer; FSD1 (Yamashita et al, 2006) and CREB3L3 (Wichmann et al, 2015) were reported to be associated with gastric cancer; CARD14 (Oudes et al, 2005) was reported to be associated with prostate cancer; LRRFIP1 (Ariake et al, 2012) was reported to be associated with colorectal cancer; and PARD3 was reported to be associated with both esophageal squamous cell carcinoma (Zen et al, 2009) and lung squamous cell carcinomas (Bonastre et al, 2015).…”